(Finance) – As part of the public takeover offer (OPA) totalitarian voluntary on shares Pierrela global provider of the pharmaceutical industry listed on Euronext Milan, the offeror has communicated that it holds (jointly with persons acting in concert) a participation of at least 90.29% approximately of the share capital.
This counting the 184,992 shares, corresponding to approximately 0.34% of the capital, brought into membership and actions already detained by people acting in concert, i.e. 49,412,531 shares, corresponding to approximately 89.95% of the capital.
The effectiveness of the offer is subject to threshold conditionwhich provides that the acceptances concern a total number of shares such as to allow the offeror to become the owner of an overall shareholding at least equal to 95% of the share capital. If the offeror decides to waive the threshold condition, having already declared its intention not to restore a sufficient free float to ensure the smooth running of negotiations, it will proceed with thepurchase obligation.
The objective of the OPA is delisting. The membership period will end on December 15, 2023.